Bank of America spends more than $250 million on GLP-1s

Brian Moynihan said Bank of America spends more than $250,000 on GLP-1s. Bloomberg/Getty Images Bank of America spends more than $250 million on GLP-1s for its employees. CEO Brian Moynihan said it's part of a long-term investment in employee health. GLP-1s are not only transforming corporate healthcare budgets, but a

Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.